Identification of genes and genetic networks associated with BAG3‑dependent cell proliferation and cell survival in human cervical cancer HeLa cells
- Authors:
- Published online on: August 10, 2018 https://doi.org/10.3892/mmr.2018.9383
- Pages: 4138-4146
Abstract
Introduction
Bcl-2 associated athanogene (BAG) 3 is a member of the human BAG family of co-chaperone proteins (1). The BAG domain of BAG3 protein binds to heat shock protein (HSP) 70, a major chaperone protein involved in anti-apoptosis through recovery of unfolded proteins as well as interference with pro-apoptotic cytochrome c release from mitochondria (2). BAG3 is also known to bind to phospholipase C-γ and Bcl-2, which synergistically inhibit cell death (3). In addition, BAG3 was reported to interact with dual-specificity phosphatase 6, which is involved in extracellular signal-regulated kinase de-phosphorylation, resulting in the induction of cell proliferation (4). BAG3 possesses an N-terminal WW domain and a C-terminal PxxP domain that interact with partner proteins other than HSP70, resulting in modulation of various biological processes such as anti-apoptosis, proliferation, cell adhesion, metastasis, invasion, and autophagy (3,5–7).
Under physiological conditions, constitutive expression levels of BAG3 are low in normal cells other than muscle cells. BAG3 expression is induced under stress conditions such as heavy metals, heat, oxidative stress, ultrasound, and starvation (8–13). The expression of BAG3 is reported to be regulated partially by the activation of heat shock transcription factor 1 as in the cases of HSPs (14). In addition, BAG3 and some HSP family proteins are controlled by hypoxia-induced factor 1, which is highly expressed under hypoxic conditions, such as in tumor microenvironments (15). However, many studies have revealed that BAG3 expression is also elevated under normoxic conditions in numerous tumor cells including breast cancer, prostate cancer, ovarian cancer, colorectal cancer, melanoma, and osteosarcoma (3,6,16–19). This is probably because BAG3 contributes to cell proliferation as well as cell survival through interaction with anti-apoptotic proteins such as Bcl-2, and myeloid leukemia cell differentiation protein 1 that are overexpressed in cancer (20). Indeed, overexpression of BAG3 correlates with dismal prognosis in melanoma and several carcinomas (6,16,18).
An impressive recent study revealed functional categories of BAG3 partner proteins by using novel comprehensive proteome analysis, called quantitative immunoprecipitation combined with knockdown (QUICK) (21). Protein analysis through evolutionary relationships classification of the data obtained from QUICK demonstrated that the BAG3 interactome includes transcription factors, indicating that BAG3-dependent cell proliferation and survival may be mediated by gene transcription, at least in part. Despite accumulating data on the functions of BAG3 and its protein-protein interactions, neither the transcripts associated with BAG3 overexpression in cancer cells, nor their functions, are fully elucidated. Here, we performed DNA microarray-based comprehensive transcriptome analysis and bioinformatics on two BAG3 knockout (KO) HeLa cell clones established using the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 (CRISPR associated protein 9) genome editing system. Finally, we identified genetic networks of transcripts associated with proliferation and cell survival, which may be dependent on BAG3 expression.
Materials and methods
Cell culture
Human cervical cancer HeLa cells were newly obtained from the Human Science Research Resources Bank, Japan Health Sciences Foundation (Tokyo, Japan) for this experiment. Cells were cultured in E-MEM (Wako Pure Chemical Industries, Ltd., Osaka, Japan) supplemented 10% fetal bovine serum (Equitech-Bio, Inc., Kerrville, TX, USA) and 1% penicillin/streptomycin (Nacali Tesque, Inc., Kyoto, Japan).
Establishment of BAG3 KO HeLa cell clones
In the present study, the BAG3 gene was deleted using the CRISPR-Cas9 genome editing system as described below. For the expression of Cas9 protein and guide RNA targeting the BAG3 gene, pX362 vector (Addgene, Cambridge, MA, USA) was used as previously described (22). After the digestion of pX362 with BbsI, the oligonucleotides 5′-caccGAGACTCCATCCTCTGCCAA-3′ and 5′-aaacTTGGCAGAGGATGGAGTCTC-3′ (upper and lower case letters are protospacer sequence and additional sequence to clone into the BbsI site, respectively) corresponding to the single guide RNA target sequence in exon 1 of BAG3 were annealed and subcloned into the BbsI site of pX362. The constructed plasmid was transfected into HeLa cells with Effectene Transfection Reagent (Qiagen GmbH, Hilden, Germany) according to the manufacture's procedure. The DNA-transfected HeLa cells were selected by treatment with 1 µg/ml of puromycin (Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 48 h, followed by limited dilution to obtain the colonies. The grown colonies were picked up and expanded. After initial screening by immunoblotting with anti-BAG3 antibody, genomic DNA from the HeLa cell clones was prepared and used for polymerase chain reaction to examine the sequence of the DNA fragment containing the target site. The forward and reverse primer sequences were 5′-CCAGCCTGTGTTTCTCCACTT-3′ and 5′-CTGTCTTTGCTGGGTGACCT-3′, respectively.
SDS-PAGE and western blot analysis
Cells were dissolved in a lysis buffer (150 mM NaCl, 1% Nonidet P-40 and 50 mM Tris-HCl, pH 8.0) containing a protease inhibitor cocktail (Nacali Tesque, Inc.). SDS-PAGE and Western blotting were carried out as described elsewhere (12). Proteins were detected using the following primary antibodies: Anti-BAG3 rabbit monoclonal antibody (GeneTex Inc., Irvine, CA, USA) and anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mouse monoclonal antibody (as a loading reference; Proteintech, Rosemont, IL, USA). Secondary fluorescent-conjugated anti-mouse and anti-rabbit IgGs (LI-COR Bioscience, Lincoln, NE, USA) were also used. Protein expression levels and images were acquired using an Odyssey Infrared Imager (LI-COR Biosciences).
Cell counting assay
Ten thousand cells were seeded in 24-well culture plates for cell counting. After trypsinization, the trypan blue dye exclusion test was performed, by mixing cell suspension with an equal amount of phosphate-buffered saline containing 0.4% trypan blue. The number of cells excluding the dye was counted by using an EVE™ automatic cell counter (NanoEnTek, Inc., Seoul, Korea).
Cell cycle analysis
Fifty thousand cells were cultured in 60 mm culture dishes two days before cell cycle analysis. For flow cytometry, cells were fixed with 70% ice cold ethanol for at least 1 h, and subsequently treated with 0.25 mg/ml RNase A (Nacali Tesque, Inc.) and SYTOX AADvanced (Thermo Fisher Scientific, Inc.) as described (23). The samples were finally analyzed by flow cytometry using a Novocyte flow cytometer (Novocyte, San Diego, CA, USA). A total of 10,000 cells per sample were analyzed in each experiment. Distribution of cells in each cell cycle phase was analyzed based on the Watson model (24).
RNA isolation
Total RNA was extracted from cells using a NucleoSpin® RNA isolation kit (Macherey-Nagel GmbH & Co., Düren, Germany) and treated with DNase I for 20 min at room temperature to remove residual genomic DNA. The quality of the RNA was analyzed using a Bioanalyzer 2100 and a RNA6000 Nano LabChip kit (Agilent Technologies, Inc., Santa Clara, CA, USA). RNA samples with RNA integrity number values above 9.5 were considered acceptable.
Gene expression analysis
Microarray and computational gene expression analyses were performed using a GeneChip® system with a Human Genome U133-plus 2.0 array (Affymetrix, Inc., Santa Clara, CA, USA), which was spotted with ~55,000 probe sets, as previously described. Samples for array hybridization were prepared as described in the Affymetrix GeneChip® Expression Technical Manual. The scanned arrays were analyzed using the GeneChip Analysis Suite Software (Affymetrix, Inc.). The microarray data were deposited in the Gene Expression Omnibus: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103475.
For global normalization, microarray signals were processed using a standard MAS5.0 algorithm. The obtained hybridization intensity data and qualities were checked using the GeneSpring® software (Agilent Technologies, Inc.). Observed signals were normalized and genes that had no significant signals were ignored to reduce noise. In addition, probe sets targeting specific RefSeq transcripts, based on the RefDIC database, were extracted (25). Principal component analyses (PCA) were performed using R v3.2.1. Venn diagrams and hierarchical clustering from the obtained normalized intensity data were produced using GeneSpring® software. Ward's linkage and squared Euclidean distance were utilized in hierarchical clustering.
In order to examine the molecular functions of differentially expressed genes and gene networks, data were analyzed using Ingenuity Pathways Analysis (IPA) tools (Ingenuity Systems, Mountain View, CA, USA), a web-delivered application that enables the identification, visualization, and exploration of molecular interaction networks in gene expression data. The top five molecular functions were identified and the gene networks containing the molecules were visualized to provide information about interactions involving genes that were up- or downregulated by BAG3 deletion.
Statistical analysis
Data are presented as the mean ± standard deviation (SD). The statistical significance of differences between data sets was analyzed using one-way analysis of variance (ANOVA) with post-hoc Tukey HSD tests (R v3.2.1). P<0.05 was considered to indicate a statistically significant difference. In microarray analysis, raw P-values were adjusted by calculating false discovery rate using the Benjamini-Hochberg method (GeneSpring® software; Agilent Technologies, Inc.).
Results
Establishment and characterization of BAG3 KO HeLa cell clones
To confirm the role of BAG3 in cell proliferation and survival in HeLa cells, we constructed BAG3 KO HeLa cell clones using a CRISPR-Cas9 genome editing system. Among isolated clones, two clones, designated as KO1 and KO2, were selected as BAG3 KO candidates. This selection was based on the result of initial screening by western blotting using anti-BAG3 antibody, since it is possible that translation can be initiated from an in-frame ATG in nonsense mutation near the 5′ region of an open reading frame (26). After the initial screening, we confirmed the sequence of exon 1 of the BAG3 gene and found that two clones contained a 14 or 1 bp deletion in exon 1 of both alleles, respectively, resulting in a frame-shift and premature termination of BAG3 translation (Fig. 1A). We confirmed that BAG3 protein expression was diminished as a result of the deletions in the BAG3 gene by repeated western blot analysis (Fig. 1B). The two selected BAG3 KO clones and the wild-type (WT) control cells were cultured for 7 days to assess whether BAG3 deletion affected the number of viable cells in culture conditions. As a result of BAG3 deletion, the number of viable cells was significantly decreased in both clones (Fig. 1C). This result is consistent with involvement of BAG3 with cell proliferation and/or cell survival even under culture conditions without exogenous cytotoxic stimulation (e.g., heat or oxidative stress).
Cell cycle distribution in BAG3 KO HeLa cell clones. Established BAG3 KO HeLa cell clones showed decreased numbers of viable cells, indicating that BAG3 deletion led to cell cycle delay and/or cell death. To examine the effect of BAG3 on cell cycle progression and cell survival during cell culture, we performed cell cycle analysis using flow cytometry. Cell cycle analysis revealed that the populations of cells in Sub G1 and G2/M phase were increased in both BAG3 KO clones (Fig. 2), indicating that BAG3 is involved in both cell cycle progression and anti-apoptosis under normal culture conditions in HeLa cells.
Global gene expression analysis in BAG3 KO HeLa cell clones
In order to analyze gene expression associated with BAG3, we performed microarray analysis in WT and two BAG3 KO HeLa cell clones. After normalization of obtained intensities using the MAS5.0 algorithm, we performed PCA on gene expression data. This revealed that the gene expression patterns in WT cells were markedly distinct from those in BAG3 KO cells (Fig. 3A). However, the gene expression pattern in clone KO1 was also distinct from that in KO2, which we assumed was due to normal/stochastic heterogeneity between isolated clones. Therefore, we attempted to identify common up- or downregulated genes between two established clones to narrow down the potential BAG3-target genes. Of the 54,675 probe sets analyzed, 28,719 reliable probe sets were extracted using RefDIC database, since the probes on this type of array include unreliable probes that were designed based on a classical database. Among them, 5,436 probe sets were defined as statistically significant based on one-way ANOVA with post-hoc Tukey HSD and Benjamini-Hochberg procedure. Furthermore, we identified 1,274 probe sets that were differentially expressed by a factor of 2.0 or greater in either WT cells or BAG3 KO clones. Among them, 102 and 284 probe sets were commonly up- or downregulated in BAG3 KO clones, respectively (Fig. 3B).
Computational analysis of genes responsive to BAG3 deletion and gene network analysis
Venn diagrams of differentially expressed probes showed that 102 and 284 genes were up- and downregulated by BAG3 deletion, respectively. In the present study, we further performed a bioinformatics analysis to identify the molecular/cellular functions, and the genetic networks of differentially expressed genes, in order to elucidate the mechanisms underlying cell death and cell cycle delay in response to BAG3 deletion. From the analysis of molecular and cellular function based on IPA knowledge base, we found that ‘cell death and cell survival’ and ‘cellular growth and proliferation’ were among the top five functions for up- and downregulated genes, respectively (Table I).
In order to elucidate the interactions between the up- or downregulated genes, we performed a gene network analysis. The analysis identified an upregulated gene network (Network up) containing 12 genes, including cyclin D1 (CCND1), matrix metalloproteinase 2 (MMP2), platelet derived growth factor C (PDGFC), runt-related transcription factor 2 (RUNX2), peroxisome proliferator-activated receptor γ (PPARG) and coagulation factor II thrombin receptor (F2R) (Fig. 4A and Table II). The downregulated gene network (Network down) contained 15 genes, including TIMP metallopeptidase inhibitor 3 (TIMP3), Krupper like factor 4 (KLF4), epithelial cell adhesion molecule (EPCAM), erb-b2 receptor tyrosine kinase 4 (ERBB4), and bone morphogenetic protein 2 (BMP2) (Fig. 4B and Table II). Among them, BAG3 has already been reported to interact with MMP2 and PDGFC (6,21), but not with other genes. In addition, the BioGRID database, a depository of interaction datasets including the results of recent interactome analyses, also did not report interaction between BAG3 and the genes in the networks we identified, other than MMP2 and PDGFC, suggesting that the expression changes of most transcripts identified here may have been independent of BAG3 interaction with proteins coded by these genes.
Discussion
The DNA microarray has been a standard technology for elucidating genome-wide gene expression signatures in life science research fields. In this study, we addressed the role of BAG3 in gene transcription by combining transcriptome and computational analysis in two stable BAG3 KO HeLa cell clones. Currently, more than 400 BAG3 partner proteins are listed in public and commercial databases. Among them, we identified MMP2 and PDGFC as transcriptionally upregulated by BAG3 deletion. MMP2 is known to contribute to tumor cell apoptosis, probably through the degradation of poly (ADP-ribose) polymerase, which repairs DNA single-strand breaks (27,28). In contrast, PDGFC shows anti-apoptotic effect and promotes cell proliferation (29,30). These genes seem to compete with each other at the level of transcription and probably also at the post-translational level by interacting with BAG3. Interestingly, only these two genes were identified as BAG3-related genes in our gene networks. It is possible that the upregulation of MMP2 and PDGFC transcripts resulted from destabilization of MMP2 and PDGFC (negative feedback through protein degradation) in the absence of BAG3. Also of note, we found that the transcription factors RUNX2 and PPARG, not previously reported to interact with BAG3, were markedly upregulated by BAG3 deletion in two BAG3 KO clones established in this study. RUNX2 was reported to be involved in cell proliferation under normal conditions as well as cell survival under conditions of stress (31,32). PPARG was overexpressed in cancer but its excessive activation led to growth inhibition and apoptosis (33). Neither transcription factor has yet been reported to interact with BAG3, but both are known to enhance the expression of MMP2, indicating that BAG3 may be indirectly involved in RUNX2- and PPARG-dependent transcription of MMP2. BAG3 deletion also upregulated expression of CCND1, known to be a downstream target of RUNX2 and PPARG (34,35). CCND1 is well known as a G1 cyclin, and degradation of this protein results in G1 arrest. However, overexpression of CCND1 perturbs normal replication and induces DNA damage (36), resulting in apoptotic cell death. Parathyroid hormone like hormone (PTHLH) is positive regulator of CCND1 transcription through RhoA/ROCK signaling (37). F2R is also known to promote CCND1 expression through the transcription factor c-Fos (38). Nephroblastoma overexpressed (NOV) inhibits cell proliferation when overexpressed in Ewing's sarcoma cells (39). It is conceivable that BAG3 indirectly suppresses transcription of the genes in the Network up to promote cell cycle progression and cell survival in HeLa cells.
In contrast to genes identified in the Network up, some genes were downregulated by BAG3 deletion. Among downregulated genes, ERBB4, TIMP3, KLF4, and BMP2 were located in the central region of the Network down. ERBB4 encodes HER4, a tyrosine kinase receptor belonging to the epidermal growth factor receptor family. ERBB4 is overexpressed in Ewing's sarcoma cells and activates the PI3K-Akt cascade, resulting in the promotion of cell growth and survival (40). In addition, ERBB4 is known to enhance the expression of downstream molecules such as early growth response 1 (EGR1) and TIMP3 (41). EGR1 is a transcription factor that plays a critical role in cell growth and survival (42,43). TIMP3 acts as a tissue inhibitor of MMP2 (44). Thus, downregulation of ERBB4 and TIMP3 may lead to the activation of overexpressed MMP2 in BAG3 KO HeLa cells. TIMP3 also regulates the expression of KLF4. KLF4 is a transcription factor linked to tumor cell growth by a study showing that its downregulation inhibits the proliferation of cancer cells (45). Mutation of KLF4 leads to a decrease in the level of EPCAM (46), high expression of which in gastric cancer is linked to proliferation (47). BMP2 inhibits apoptosis through the activation of BMP receptor 2 (48). Furthermore, BMP2 was reported to upregulate expression of TIMP3 and KLF4 (49). The BMP2-TIMP3 and BMP2-KLF4 signaling axes may also contribute to proliferation and cell survival through BAG3-dependent transcription.
In this study, we identified two BAG3-dependent genetic networks associated with cellular growth and proliferation as well as cell death and survival. These findings will provide a molecular basis for understanding BAG3-dependent transcriptional regulation of genes in cancer cells. Further investigation is needed to identify the BAG3-binding, up-stream transcriptional regulators of the genes listed in the genetic networks we identified.
Acknowledgements
Not applicable.
Funding
The present study was supported in part by the JSPS KAKENHI (grant nos. 16K20309 and 17K01353).
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Authors' contributions
YF and YT conceived the study, designed the experiments, wrote the manuscript and performed the experiments. TH and SM also performed the experiments. HI and HM provided the materials and performed genome editing. TY and AH provided materials for microarray analysis and were involved in data analysis.
Ethics approval and consent to participate
Not applicable.
Patient consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Glossary
Abbreviations
Abbreviations:
BAG |
BCL2-associated athanogene |
BMP2 |
bone morphogenetic protein 2 |
CCND1 |
cyclin D1 |
Cas9 |
CRISPR associated protein 9 |
CRISPR |
clustered regularly interspaced short palindromic repeats |
EPCAM |
epithelial cell adhesion molecule |
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
EGR1 |
early growth response 1 |
F2R |
coagulation factor II thrombin receptor |
IPA |
Ingenuity Pathways Analysis |
KLF4 |
Kruppel like factor 4 |
NOV |
nephroblastoma overexpressed |
PCA |
principal component analyses |
PDGFC |
platelet derived growth factor C |
PPARG |
peroxisome proliferator activated receptor γ |
PTHLH |
parathyroid hormone like hormone |
QUICK |
quantitative immunoprecipitation combined with knockdown |
RUNX2 |
runt-related transcription factor 2 |
TIMP3 |
TIMP metallopeptidase inhibitor 3 |
References
Behl C: Breaking BAG: The co-chaperone BAG3 in health and disease. Trends Pharmacol Sci. 37:672–688. 2016. View Article : Google Scholar : PubMed/NCBI | |
Rosati A, Ammirante M, Gentilella A, Basile A, Festa M, Pascale M, Marzullo L, Belisario MA, Tosco A, Franceschelli S, et al: Apoptosis inhibition in cancer cells: A novel molecular pathway that involves BAG3 protein. Int J Biochem Cell Biol. 39:1337–1342. 2017. View Article : Google Scholar | |
Kassis JN, Guancial EA, Doong H, Virador V and Kohn EC: CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins. Exp Cell Res. 312:2962–2971. 2006. View Article : Google Scholar : PubMed/NCBI | |
Falco A, Festa M, Basile A, Rosati A, Pascale M, Florenzano F, Nori SL, Nicolin V, Di Benedetto M, Vecchione ML, et al: BAG3 controls angiogenesis through regulation of ERK phosphorylation. Oncogene. 31:5153–5161. 2012. View Article : Google Scholar : PubMed/NCBI | |
Shi H, Xu H, Li Z, Zhen Y, Wang B, Huo S, Xiao R and Xu Z: BAG3 regulates cell proliferation, migration, and invasion in human colorectal cancer. Tumour Biol. 37:5591–5597. 2016. View Article : Google Scholar : PubMed/NCBI | |
Suzuki M, Iwasaki M, Sugio A, Hishiya A, Tanaka R, Endo T, Takayama S and Saito T: BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells. Cancer Lett. 303:65–71. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kathage B, Gehlert S, Ulbricht A, Lüdecke L, Tapia VE, Orfanos Z, Wenzel D, Bloch W, Volkmer R, Fleischmann BK, et al: The cochaperone BAG3 coordinates protein synthesis and autophagy under mechanical strain through spatial regulation of mTORC1. Biochim Biophys Acta. 1864:62–75. 2017. View Article : Google Scholar : PubMed/NCBI | |
Bonelli P, Petrella A, Rosati A, Romano MF, Lerose R, Pagliuca MG, Amelio T, Festa M, Martire G, Venuta S, et al: BAG3 protein regulates stress-induced apoptosis in normal and neoplastic leukocytes. Leukemia. 18:358–360. 2004. View Article : Google Scholar : PubMed/NCBI | |
Tabuchi Y, Ando H, Takasaki I, Feril LB Jr, Zhao QL, Ogawa R, Kudo N, Tachibana K and Kondo T: Identification of genes responsive to low intensity pulsed ultrasound in a human leukemia cell line Molt-4. Cancer Lett. 246:149–156. 2007. View Article : Google Scholar : PubMed/NCBI | |
Jung SE, Kim YK, Youn DY, Lim MH, Ko JH, Ahn YS and Lee JH: Down-modulation of Bis sensitizes cell death in C6 glioma cells induced by oxygen-glucose deprivation. Brain Res. 1349:1–10. 2010. View Article : Google Scholar : PubMed/NCBI | |
Pagliuca MG, Lerose R, Cigliano S and Leone A: Regulation by heavy metals and temperature of the human BAG-3 gene, a modulator of Hsp70 activity. FEBS Lett. 541:11–15. 2003. View Article : Google Scholar : PubMed/NCBI | |
Yunoki T, Kariya A, Kondo T, Hayashi A and Tabuchi Y: The combination of silencing BAG3 and inhibition of the JNK pathway enhances hyperthermia sensitivity in human oral squamous cell carcinoma cells. Cancer Lett. 335:52–57. 2013. View Article : Google Scholar : PubMed/NCBI | |
Yunoki T, Tabuchi Y, Hayashi A and Kondo T: Network analysis of genes involved in the enhancement of hyperthermia sensitivity by the knockdown of BAG3 in human oral squamous cell carcinoma cells. Int J Mol Med. 38:236–242. 2016. View Article : Google Scholar : PubMed/NCBI | |
Franceschelli S, Rosati A, Lerose R, De Nicola S, Turco MC and Pascale M: Bag3 gene expression is regulated by heat shock factor 1. J Cell Physiol. 215:575–577. 2008. View Article : Google Scholar : PubMed/NCBI | |
Colvin TA, Gabai VL, Gong J, Calderwood SK, Li H, Gummuluru S, Matchuk ON, Smirnova SG, Orlova NV, Zamulaeva IA, et al: Hsp70-Bag3 interactions regulate cancer-related signaling networks. Cancer Res. 74:4731–4740. 2014. View Article : Google Scholar : PubMed/NCBI | |
Staibano S, Mascolo M, Di Benedetto M, Vecchione ML, Ilardi G, Di Lorenzo G, Autorino R, Salerno V, Morena A, Rocco A, et al: BAG3 protein delocalisation in prostate carcinoma. Tumour Biol. 31:461–469. 2010. View Article : Google Scholar : PubMed/NCBI | |
Tang JT, Wang JL, Du W, Hong J, Zhao SL, Wang YC, Xiong H, Chen HM and Fang JY: MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer. Carcinogenesis. 32:1207–1215. 2011. View Article : Google Scholar : PubMed/NCBI | |
Ammirante M, Rosati A, Arra C, Basile A, Falco A, Festa M, Pascale M, D'Avenia M, Marzullo L, Belisario MA, et al: IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci USA. 107:pp. 7497–7502. 2010; View Article : Google Scholar : PubMed/NCBI | |
Yunoki T, Tabuchi Y, Kondo T, Ishii Y and Hayashi A: Overexpression of the anti-apoptotic protein BAG3 in human choroidal melanoma: A case report. Oncol Lett. 13:4169–4172. 2017. View Article : Google Scholar : PubMed/NCBI | |
Boiani M, Daniel C, Liu X, Hogarty MD and Marnett LJ: The stress protein BAG3 stabilizes Mcl-1 protein and promotes survival of cancer cells and resistance to antagonist ABT-737. J Biol Chem. 288:6980–6990. 2013. View Article : Google Scholar : PubMed/NCBI | |
Chen Y, Yang LN, Cheng L, Tu S, Guo SJ, Le HY, Xiong Q, Mo R, Li CY, Jeong JS, et al: Bcl2-associated athanogene 3 interactome analysis reveals a new role in modulating proteasome activity. Mol Cell Proteomics. 12:2804–2819. 2013. View Article : Google Scholar : PubMed/NCBI | |
Ito T, Hayashida M, Kobayashi S, Muto N, Hayashi A, Yoshimura T and Mori H: Serine racemase is involved in d-aspartate biosynthesis. J Biochem. 160:345–353. 2016. View Article : Google Scholar : PubMed/NCBI | |
Furusawa Y, Yamanouchi Y, Iizumi T, Zhao WL, Mitsuhashi Y, Morita A, Enomoto A, Tabuchi Y and Kondo T: Checkpoint kinase 2 is dispensable for regulation of the p53 response but is required for G2/M arrest and cell survival in cells with p53 defects under heat stress. Apoptosis. 22:1225–1234. 2017. View Article : Google Scholar : PubMed/NCBI | |
Watson JV, Chambers SH and Smith PJ: A pragmatic approach to the analysis of DNA histograms with a definable G1 peak. Cytometry. 8:1–8. 1987. View Article : Google Scholar : PubMed/NCBI | |
Hijikata A, Kitamura H, Kimura Y, Yokoyama R, Aiba Y, Bao Y, Fujita S, Hase K, Hori S, Ishii Y, et al: Construction of an open-access database that integrates cross-reference information from the transcriptome and proteome of immune cells. Bioinformatics. 23:2934–2941. 2007. View Article : Google Scholar : PubMed/NCBI | |
Makino S, Fukumura R and Gondo Y: Illegitimate translation causes unexpected gene expression from on-target out-of-frame alleles created by CRISPR-Cas9. Sci Rep. 6:396082016. View Article : Google Scholar : PubMed/NCBI | |
Kwan JA, Schulze CJ, Wang W, Leon H, Sariahmetoglu M, Sung M, Sawicka J, Sims DE, Sawicki G and Schulz R: Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J. 18:690–692. 2004. View Article : Google Scholar : PubMed/NCBI | |
Aldonyte R, Brantly M, Block E, Patel J and Zhang J: Nuclear localization of active matrix metalloproteinase-2 in cigarette smoke-exposed apoptotic endothelial cells. Exp Lung Res. 35:59–75. 2009. View Article : Google Scholar : PubMed/NCBI | |
McDermott U, Ames RY, Iafrate AJ, Maheswaran S, Stubbs H, Greninger P, McCutcheon K, Milano R, Tam A, Lee DY, et al: Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitors. Cancer Res. 69:3937–3946. 2009. View Article : Google Scholar : PubMed/NCBI | |
Tang Z, Arjunan P, Lee C, Li Y, Kumar A, Hou X, Wang B, Wardega P, Zhang F, Dong L, et al: Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation. J Exp Med. 207:867–880. 2010. View Article : Google Scholar : PubMed/NCBI | |
Lucero CM, Vega OA, Osorio MM, Tapia JC, Antonelli M, Stein GS, van Wijnen AJ and Galindo MA: The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines. J Cell Physiol. 228:714–723. 2013. View Article : Google Scholar : PubMed/NCBI | |
Sugimoto H, Nakamura M, Yoda H, Hiraoka K, Shinohara K, Sang M, Fujiwara K, Shimozato O, Nagase H and Ozaki T: Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death. Cell Death Dis. 6:e19142015. View Article : Google Scholar : PubMed/NCBI | |
Krishnan A, Nair SA and Pillai MR: Biology of PPAR gamma in cancer: A critical review on existing lacunae. Curr Mol Med. 7:532–540. 2007. View Article : Google Scholar : PubMed/NCBI | |
Owens TW, Rogers RL, Best S, Ledger A, Mooney AM, Ferguson A, Shore P, Swarbrick A, Ormandy CJ, Simpson PT, et al: Runx2 is a novel regulator of mammary epithelial cell fate in development and breast cancer. Cancer Res. 74:5277–5286. 2014. View Article : Google Scholar : PubMed/NCBI | |
Sharma C, Pradeep A, Pestell RG and Rana B: Peroxisome proliferator-activated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes. J Biol Chem. 279:16927–16938. 2004. View Article : Google Scholar : PubMed/NCBI | |
Shimura T, Ochiai Y, Noma N, Oikawa T, Sano Y and Fukumoto M: Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells. Cell Cycle. 12:773–782. 2013. View Article : Google Scholar : PubMed/NCBI | |
Wang G, Woods A, Sabari S, Pagnotta L, Stanton LA and Beier F: RhoA/ROCK signaling suppresses hypertrophic chondrocyte differentiation. J Biol Chem. 279:13205–13214. 2004. View Article : Google Scholar : PubMed/NCBI | |
Parrales A, Palma-Nicolás JP, López E and López-Colomé AM: Thrombin stimulates RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression. J Cell Physiol. 222:302–312. 2010. View Article : Google Scholar : PubMed/NCBI | |
Benini S, Perbal B, Zambelli D, Colombo MP, Manara MC, Serra M, Parenza M, Martinez V, Picci P and Scotlandi K: In Ewing's sarcoma CCN3(NOV) inhibits proliferation while promoting migration and invasion of the same cell type. Oncogene. 24:4349–4361. 2005. View Article : Google Scholar : PubMed/NCBI | |
Mendoza-Naranjo A, El-Naggar A, Wai DH, Mistry P, Lazic N, Ayala FR, da Cunha IW, Rodriguez-Viciana P, Cheng H, Tavares Guerreiro, Fregnani JH, et al: ERBB4 confers metastatic capacity in Ewing sarcoma. EMBO Mol Med. 5:1087–1102. 2013. View Article : Google Scholar : PubMed/NCBI | |
Capone C, Dabertrand F, Baron-Menguy C, Chalaris A, Ghezali L, Domenga-Denier V, Schmidt S, Huneau C, Rose-John S, Nelson MT and Joutel A: Mechanistic insights into a TIMP3-sensitive pathway constitutively engaged in the regulation of cerebral hemodynamics. Elife. 5(pii): e175362016. View Article : Google Scholar : PubMed/NCBI | |
Zins K, Pomyje J, Hofer E, Abraham D, Lucas T and Aharinejad S: Egr-1 upregulates Siva-1 expression and induces cardiac fibroblast apoptosis. Int J Mol Sci. 15:1538–1553. 2014. View Article : Google Scholar : PubMed/NCBI | |
Baron V, De Gregorio G, Krones-Herzig A, Virolle T, Calogero A, Urcis R and Mercola D: Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo. Oncogene. 22:4194–4204. 2003. View Article : Google Scholar : PubMed/NCBI | |
Jackson HW, Defamie V, Waterhouse P and Khokha R: TIMPs: Versatile extracellular regulators in cancer. Nat Rev Cancer. 17:38–53. 2017. View Article : Google Scholar : PubMed/NCBI | |
Tien YT, Chang MH, Chu PY, Lin CS, Liu CH and Liao AT: Downregulation of the KLF4 transcription factor inhibits the proliferation and migration of canine mammary tumor cells. Vet J. 205:244–253. 2015. View Article : Google Scholar : PubMed/NCBI | |
Liu YN, Abou-Kheir W, Yin JJ, Fang L, Hynes P, Casey O, Hu D, Wan Y, Seng V, Sheppard-Tillman H, et al: Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition. Mol Cell Biol. 32:941–953. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kroepil F, Dulian A, Vallböhmer D, Geddert H, Krieg A, Vay C, Topp SA, Am Esch JS, Baldus SE, Gires O, et al: High EpCAM expression is linked to proliferation and lauren classification in gastric cancer. BMC Res Notes. 6:2532013. View Article : Google Scholar : PubMed/NCBI | |
Liu Z, Shen J, Pu K, Katus HA, Plöger F, Tiefenbacher CP, Chen X and Braun T: GDF5 and BMP2 inhibit apoptosis via activation of BMPR2 and subsequent stabilization of XIAP. Biochim Biophys Acta. 1793:1819–1827. 2009. View Article : Google Scholar : PubMed/NCBI | |
Li Q, Kannan A, Das A, Demayo FJ, Hornsby PJ, Young SL, Taylor RN, Bagchi MK and Bagchi IC: WNT4 acts downstream of BMP2 and functions via β-catenin signaling pathway to regulate human endometrial stromal cell differentiation. Endocrinology. 154:446–457. 2013. View Article : Google Scholar : PubMed/NCBI |